Arman Oruc is co-chair of the firm’s Antitrust and Competition practice. He specializes in antitrust related issues, including regulatory clearance and approval of mergers and acquisitions, government investigations, antitrust litigation and antitrust risks associated with strategic business practices. Mr. Oruc was most recently part of the founding team of a life sciences company helping grow the start-up into a late-stage clinical platform company. Mr. Oruc’s experience in both merger clearance and antitrust litigation, combined with his in-house experience, gives him a unique perspective in his practice.
Areas of Practice
Domaines D’Expertise





Mr. Oruc has advised on antitrust issues associated with countless consummated and proposed transactions for private equity and public company clients. He has shepherded transactions through the FTC, DOJ and competition authorities outside of the US. His litigation experience includes single company monopolization cases, allegations of abuse of intellectual property, standard setting activities, foreclosure allegations, as well as successful amnesty applications in cartel investigations.

Representative matters:

  • BioDelivery Sciences International, Inc. in its proposed acquisition by Collegium Pharmaceutical for $604 million.
  • Ampersand Capital Partners in its sale of Nexelis Group, Inc. to Q2 Solutions, a wholly owned subsidiary of IQVIA, Inc.
  • Audacious Inquiry on its agreement to be acquired by PointClickCare Technologies.
  • Nimbus Therapeutics in its proposed acquisition by Celgene and Nimbus's related antitrust litigation against Celgene and Bristol Myers Squibb.
  • Trillium Therapeutics in its sale to Pfizer for $2.26 billion.
  • OneLogin in its acquisition by One Identity LLC, a subsidiary of Quest Software Inc.
  • Syndax in its strategic collaboration with Incyte for up to $152 million.
  • A non-US company in a grand jury investigation by the DOJ, Antitrust Division.
  • Co-counsel for Weyerhaeuser in the seminal monopsonization litigations.*
  • Lead counsel for Staples in antitrust litigations and government investigations related to product design and strategy issues surrounding private label ink cartridges compatible with HP-branded printers.*
  • Lead counsel for Ericsson in a Sherman Act challenge brought by “positioning” technology company whose technology was excluded from the 4G standard.*
  • Lead antitrust counsel to the standard-setting organization through the format war between HD DVD and Blu-ray technologies.*
  • Represented MasterCard in numerous antitrust litigations against the DOJ, American Express, Discover and Visa.*

*Denotes experience prior to joining Goodwin.

Professional Experience

Mr. Oruc serves on Law360’s Editorial Advisory Board for Life Sciences.

Prior to joining Goodwin, Mr. Oruc was part of the founding team of Biosplice Therapeutics, Inc. where he served as the Chief Legal Officer and a member of the Board. Prior to Biosplice, Mr. Oruc practiced as an antitrust lawyer for seventeen years during which he helped launch Simpson Thacher & Bartlett’s Washington, D.C. office and expand the firm’s merger review and antitrust litigation practices.


Mr. Oruc has been selected for inclusion in The Legal 500 US 2022.

In The News









J.D., 1996
University of California, Berkeley
M. Phil., Economics, 1993
Cambridge University
B.A., Economics, 1992
Skidmore College



New York
District of Columbia


U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. District Court for the District of Columbia
U.S. Court of Appeals for the Second Circuit
U.S. Court of Appeals for the District of Columbia Circuit
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique